Replies to Post #97 onEvolus (EOLS)

Replies to post #97 on Evolus (EOLS)

Replies to #97 on Evolus (EOLS)

08/30/19 4:06 PM

#98 RE: Ortho91 #97

Medytox points to the upcoming ITC analysis of both companies’ strains, which would seem to be more objective than a test conducted by Daewoong.

08/30/19 4:07 PM

#99 RE: Ortho91 #97

RVNC will be great but stop with your continued discounting of EOLS. Play both.

No thanks. I don’t think EOLS’ business model will be successful.